Results 311 to 320 of about 165,707 (370)

Effects of Mobilization Within 24 Hours Based on the ICU Mobility Scale in Cancer Patients: A Randomized Controlled Clinical Trial “Mobilization Based on the ICU Mobility Scale”

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objective Abdominal cancer surgery leads to loss of functional capacity. The objective was to evaluate the effects of mobilization within 24 h applied to patients with abdominal neoplasms undergoing major surgery. Methods A randomized controlled clinical trial was carried out in the Intensive Care Unit.
Flaviana Santos de Sousa Silva   +5 more
wiley   +1 more source

Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Lymphedema secondary to multimodal breast cancer treatment is a relatively common complication that significantly impacts patients' quality of life. Despite identifying several associated risk factors, accurately assessing individual risk remains challenging.
Enrique Cano‐Lallave   +7 more
wiley   +1 more source

Evaluating Cost‐Effective Strategies for Asymptomatic Microhematuria Diagnosis: A Risk‐Based Alternative to the American Urological Association Guidelines

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives The American Urological Association (AUA) guidelines recommend evaluating asymptomatic microhematuria (MH) at ≥ 3 red blood cells per high powered field (RBCs/hpf), resulting in significant costs with limited bladder cancer detections.
Krishay Sridalla   +6 more
wiley   +1 more source

R0 Resection Rates in Minimally Invasive Versus Open Pelvic Exenteration for Colorectal Malignancies: A Systematic Review and Meta‐Analysis

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Pelvic exenteration is a curative option for select patients with locally invasive or recurrent colorectal cancer. Achieving clear margins (R0 resection) is critical for optimal oncological outcomes and quality of life.
Ernest Cheng   +7 more
wiley   +1 more source

Case Series: Natural History and Treatment of Thoracic Aortic Sarcoma

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Aortic sarcoma is a rare and aggressive malignancy with a poor prognosis despite surgical resection and vascular reconstruction. We present a case series of patients with thoracic aortic sarcoma, highlighting three distinct clinical scenarios: primary resection, resection following prior thoracic aortic endograft, and nonoperative management ...
Calvin L. Chao   +2 more
wiley   +1 more source

Neoadjuvant Immunotherapy for Resectable Dedifferentiated Liposarcoma: A National Cohort Analysis

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Neoadjuvant immunotherapy (NIT) with checkpoint blockade has been increasingly studied for soft tissue sarcomas, however, survival outcomes data are limited, and dedifferentiated liposarcoma (DDLPS) histology remains underrepresented in recent trial cohorts.
Mohammad S. Farooq   +6 more
wiley   +1 more source

Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Neoplastic pleural effusion is one in which malignant neoplastic cells are detected in the pleural fluid or in the parietal pleura. When secondary, it confirms disseminated neoplastic disease and suggests a reduced life expectancy and low quality of life.
Erlon de Avila Carvalho   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy